Adelaide A Hebert, MD | |
6500 West Loop S Ste 200a, Bellaire, TX 77401-3535 | |
(713) 500-8260 | |
(713) 524-3432 |
Full Name | Adelaide A Hebert |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 44 Years |
Location | 6500 West Loop S Ste 200a, Bellaire, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427005453 | NPI | - | NPPES |
134305505 | Medicaid | TX | |
134305501 | Other | TX | CSHCN |
87X444 | Other | TX | BCBSTX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207NP0225X | Dermatology - Pediatric Dermatology | G1035 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ut Physicians | 8426960360 | 1400 |
News Archive
Remarkable improvements in survival from childhood cancer have taken place in high- income countries over the past 50 years, but further progress is being threatened by increasingly strict research regulations and insufficient development of new drugs, according to a major new Lancet Oncology Series on improving cancer care for children and young people.
"As the CR [continuing resolution] talks between the House Republicans and the administration and Senate Democrats near their deadline, the House negotiators should put America's foreign aid budget on the table," Dick Morris, a former adviser to Sen. Trent Lott and President Clinton, writes in an opinion piece in The Hill.
Like going from a pinhole camera to a Polaroid, a significant mathematical update to the formula for a popular bioinformatics data visualization method will allow researchers to develop snapshots of single-cell gene expression not only several times faster but also at much higher-resolution.
BioMimetic Therapeutics, Inc. today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The FDA generally meets with the PMA sponsor approximately 100 days after the filing of the PMA with the purpose of discussing the status of the application.
HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.
› Verified 2 days ago
Entity Name | Ut Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
Remarkable improvements in survival from childhood cancer have taken place in high- income countries over the past 50 years, but further progress is being threatened by increasingly strict research regulations and insufficient development of new drugs, according to a major new Lancet Oncology Series on improving cancer care for children and young people.
"As the CR [continuing resolution] talks between the House Republicans and the administration and Senate Democrats near their deadline, the House negotiators should put America's foreign aid budget on the table," Dick Morris, a former adviser to Sen. Trent Lott and President Clinton, writes in an opinion piece in The Hill.
Like going from a pinhole camera to a Polaroid, a significant mathematical update to the formula for a popular bioinformatics data visualization method will allow researchers to develop snapshots of single-cell gene expression not only several times faster but also at much higher-resolution.
BioMimetic Therapeutics, Inc. today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The FDA generally meets with the PMA sponsor approximately 100 days after the filing of the PMA with the purpose of discussing the status of the application.
HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.
› Verified 2 days ago
Entity Name | Physicians Referral Service |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073574810 PECOS PAC ID: 7911801410 Enrollment ID: O20031125000953 |
News Archive
Remarkable improvements in survival from childhood cancer have taken place in high- income countries over the past 50 years, but further progress is being threatened by increasingly strict research regulations and insufficient development of new drugs, according to a major new Lancet Oncology Series on improving cancer care for children and young people.
"As the CR [continuing resolution] talks between the House Republicans and the administration and Senate Democrats near their deadline, the House negotiators should put America's foreign aid budget on the table," Dick Morris, a former adviser to Sen. Trent Lott and President Clinton, writes in an opinion piece in The Hill.
Like going from a pinhole camera to a Polaroid, a significant mathematical update to the formula for a popular bioinformatics data visualization method will allow researchers to develop snapshots of single-cell gene expression not only several times faster but also at much higher-resolution.
BioMimetic Therapeutics, Inc. today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The FDA generally meets with the PMA sponsor approximately 100 days after the filing of the PMA with the purpose of discussing the status of the application.
HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Adelaide A Hebert, MD Po Box 201088, Houston, TX 77216-1088 Ph: (713) 500-3500 | Adelaide A Hebert, MD 6500 West Loop S Ste 200a, Bellaire, TX 77401-3535 Ph: (713) 500-8260 |
News Archive
Remarkable improvements in survival from childhood cancer have taken place in high- income countries over the past 50 years, but further progress is being threatened by increasingly strict research regulations and insufficient development of new drugs, according to a major new Lancet Oncology Series on improving cancer care for children and young people.
"As the CR [continuing resolution] talks between the House Republicans and the administration and Senate Democrats near their deadline, the House negotiators should put America's foreign aid budget on the table," Dick Morris, a former adviser to Sen. Trent Lott and President Clinton, writes in an opinion piece in The Hill.
Like going from a pinhole camera to a Polaroid, a significant mathematical update to the formula for a popular bioinformatics data visualization method will allow researchers to develop snapshots of single-cell gene expression not only several times faster but also at much higher-resolution.
BioMimetic Therapeutics, Inc. today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The FDA generally meets with the PMA sponsor approximately 100 days after the filing of the PMA with the purpose of discussing the status of the application.
HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.
› Verified 2 days ago
Howard B Gerber, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6565 West Loop S, Ste. 800, Bellaire, TX 77401 Phone: 713-661-4383 | |
Dr. Leonard H. Goldberg, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6700 West Loop South, Suite #500, Bellaire, TX 77401 Phone: 713-791-9966 Fax: 713-791-9927 | |
Ming H Jih, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6700 West Loop South, Suite #500, Bellaire, TX 77401 Phone: 713-791-9966 Fax: 713-791-9927 | |
Dr. Natalie Leticia Hone Romero, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4545 Bissonnet St Ste 200, Bellaire, TX 77401 Phone: 281-456-4900 Fax: 281-456-2122 | |
Dr. Arash Kimyai-asadi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6700 West Loop South, Suite #500, Bellaire, TX 77401 Phone: 713-791-9966 Fax: 713-791-9927 | |
Dr. Richard Reza Jahan-tigh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6500 West Loop S Ste 200f, Bellaire, TX 77401 Phone: 171-350-0832 | |
Lauren Alberta-wszolek, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6565 West Loop S, Suite 800, Bellaire, TX 77401 Phone: 713-661-4383 Fax: 713-661-4346 |